Clinical Trials Browser

Neoplasm Metastasis × apatinib × Gastrointestinal × Clear all

NCT05095636 2021-10-27

Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

NCT03913182 2020-02-05

Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Recurrence